Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Starting your investment journey? Learn what to watch out for as a new investor to avoid common pitfalls and make wise choices.
27,695 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Take-Two’s leader is steering a record $1.5 billion bet on GTA VI, illustrating how blockbuster launches shape person...
Deciding between SOXX and IYW means choosing between a laser focus on chips and a wide tech umbrella. This guide brea...
If you’re thinking about buying spacex, you’re not alone. Before you buy, ask three foundational questions that cover...
When markets surge, two traps catch many investors off guard. This practical guide reveals the incredibly costly mist...
Target has stunned the market with surprising margins and a rebound in sales. This article digs into whether the rall...
Looking for steady income in a volatile market? This rock-solid dividend stock offers a 5%+ yield with durable payout...
Is a stock market crash 2026? on the horizon. This guide translates fear into a concrete action plan—emergency funds,...
A trio of XRP ETFs began trading in 2026, offering exposure to XRP without direct coin ownership. This piece reviews ...
Geopolitics are shaking energy markets, but savvy investors can find steadiness. This piece explains how Iran roiling...
Hyped up rare-earth plays attract attention, but many stumble before they mine. This guide breaks down how to assess ...
A rare historical market signal has flashed across the investing world. This article breaks down what it might mean f...